Tags : Hyperkalaemia

AstraZeneca Reports Results of Lokelma (sodium zirconium cyclosilicate) in P-III

Shots: The global P-III HARMONIZE involves assessing of Lokelma (5/10mg) vs PBO in 267 patients with hyperkalaemia in Japan, Korea, Taiwan and Russia across 47 locations P-III HARMONIZE Results: @48 hrs.: Achieved normokalaemia (mean K level 3.5-5.0 mEq/L) 93%; safety was consistent with previous trials. These results will support its registration in Japan, Korea, Taiwan […]Read More